The rising cancer incidence rate in China poses a substantial public health concern,
although there have been remarkable improvements in the country's cancer mortality and …

Gastric cancer (GC) represents a significant burden of cancer-related mortality worldwide,
underscoring an urgent need for the development of early detection strategies and precise …

Cancer nanomedicine has emerged as a promising approach to overcome the limitations of
conventional cancer therapies, offering enhanced efficacy and safety in cancer …

Over a billion people across the world experience a high rate of missed disease diagnosis,
an issue that highlights the need for diagnostic tools showing increased accuracy and …

Accurate diagnosis of chronic obstructive pulmonary disease (COPD) and exacerbations by
metabolic biomarkers enables individualized treatment. Advanced metabolic detection …

Accurate diagnosis and classification of kidney cancer are crucial for high-quality healthcare
services. However, the current diagnostic platforms remain challenges in the rapid and …

Prostate cancer (PCa) is the second most common cancer in males worldwide. The Gleason
scoring system, which classifies the pathological growth pattern of cancer, is considered one …

Thyroid nodules (TNs) have emerged as the most prevalent endocrine disorder in China.
Fine-needle aspiration (FNA) remains the standard diagnostic method for assessing TN …

Gastrointestinal cancer is a worldwide health challenge due to its dramatically increasing
prevalence and as a leading cause of cancer-related mortality. Increasing evidence has …

Polyphenols with antioxidant properties are of significant interest in medical and
pharmaceutical applications. Given the diverse range of activities of polyphenols in vivo …